Company intelligence / Profile preview

Cosnetix

Houston, Texas, United States

Ownership: Private
Development stage: Commercial

Overview

Cosnetix offers a direct-to-consumer service that analyzes an individual's DNA to provide personalized recommendations for skincare products. Their proprietary algorithm identifies genetic markers linked to sensitivities or adverse reactions to common cosmetic ingredients, helping users avoid products likely to cause irritation. The approach is grounded in scientific research and has been tested on over 2,500 samples but is not intended as a medical diagnostic tool.

Therapeutic areas: Dermatology
Modalities: Non-pharmacological therapy
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Collaboration with Baylor College of Medicine at Texas Medical Center for advanced genetic studies

Beyond the preview

Go deeper on Cosnetix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cosnetix.

Explore the full profile